Johnson

The European Medicines Agency (EMA) said on Tuesday that benefits of the Johnson & Johnson vaccine outweigh risks despite finding possible links to very rare cases of blood clots. On Tuesday, the EMA’s safety committee said a warning should be added to the product information about the “very rare sideContinue Reading